Literature DB >> 1987808

Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers.

M Strazzabosco1, S Sakisaka, T Hayakawa, J L Boyer.   

Abstract

To study how ursodeoxycholic acid (UDCA) increases biliary HCO3- concentration and alkalinizes bile, intracellular pH (pHi) and canalicular pH (pHc) were measured microfluorimetrically in isolated rat hepatocyte couplets (IRHC). Isolated perfused rat livers (IPRL) were also used to assess the roles of Cl-, HCO3-, and zone III hepatocytes. In IRHC, UDCA diminished pHi only when HCO3- was omitted. pHi recovery was inhibited by amiloride. UDCA did not affect pHi recovery from an acid load (NH4Cl) nor modify pHc (+HCO3-). In IPRL, biliary HCO3- concentration increased following UDCA despite removal of Cl- (to inhibit Cl(-)-HCO3- exchanger) or destruction of zone III hepatocytes with digitonin. Moreover, when HCO3- was omitted from the perfusate, biliary pH rose following UDCA even though the hypercholeresis was abolished. Thus 1) hepatic UDCA uptake represents an acid load that is counteracted by Na(+)-H+ exchange when HCO3- is absent; 2) UDCA does not alkalinize pHc; and 3) alkalinization of biliary pH in IPRL is not HCO3- dependent, does not involve Cl(-)-HCO3- exchange, or zonal differences in UDCA metabolism or excretion. UDCA appears to alkalinize bile by protonation within the bile duct lumen. UDCAH may then cross the biliary epithelium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987808     DOI: 10.1152/ajpgi.1991.260.1.G58

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.

Authors:  Aaron Goldman; Mohammad Shahidullah; David Goldman; Ludmila Khailova; George Watts; Nicholas Delamere; Katerina Dvorak
Journal:  Gut       Date:  2010-09-28       Impact factor: 23.059

Review 2.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.

Authors:  Emina Halilbasic; Romina Fiorotto; Peter Fickert; Hanns-Ulrich Marschall; Tarek Moustafa; Carlo Spirli; Andrea Fuchsbichler; Judith Gumhold; Dagmar Silbert; Kurt Zatloukal; Cord Langner; Uday Maitra; Helmut Denk; Alan F Hofmann; Mario Strazzabosco; Michael Trauner
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

4.  Disposition of glycosidase inhibitors in the isolated perfused rat liver: hepatobiliary and subcellular concentration gradients of 1-deoxymannojirimycin and N-methyl-1-deoxynojirimycin.

Authors:  E D Faber; J H Proost; R Oosting; D K Meijer
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

5.  Effect of glucagon on intracellular pH regulation in isolated rat hepatocyte couplets.

Authors:  D Alvaro; P Della Guardia; A Bini; A Gigliozzi; S Furfaro; T La Rosa; C Piat; L Capocaccia
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 6.  Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.

Authors:  David J Wagner; Tao Hu; Joanne Wang
Journal:  Pharmacol Res       Date:  2016-06-16       Impact factor: 7.658

7.  A phase I/II trial of irinotecan-cisplatin combined with an anti-late-diarrhoeal programme to evaluate the safety and antitumour response of this combination therapy in patients with advanced non-small-cell lung cancer.

Authors:  Y Takeda; E Tsuduki; S Izumi; M Hojo; M Kamimura; G Naka; K Kobayashi; K Kudo
Journal:  Br J Cancer       Date:  2005-12-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.